I'm thinking the compassionate use program might come into play, but the interim data will still be blinded so I doubt the FDA will agree to it.
Quote:Just a question... but if the interim data shows that B-OM is drastically positive wouldn't the FDA have to consider treating everyone with the drug instead of using a placebo?
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
